Skip to content
10-Q

Quarterly Report

Singular Genomics Systems, Inc.

0000950170-24-096192

← back to feed
Filed
Aug 13, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Jul 31, 2024 2.5M sh
Shares Diluted Q2 2024 · Jun 30, 2024 2.48M sh
Shares Diluted Q2 2024 · Jun 30, 2024 2.47M sh
Shares Diluted restated Q2 2024 · Jun 30, 2023 2.42M sh
Shares Diluted restated Q2 2024 · Jun 30, 2023 2.41M sh
Stock Repurchased Q2 2024 · Jun 30, 2024 $0
Stock Repurchased Q2 2024 · Jun 30, 2023 $13K
Capex Q2 2024 · Jun 30, 2024 $26K
Capex Q2 2024 · Jun 30, 2023 $468K
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$41.74M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$37.93M
Long Term Debt Q2 2024 · Jun 30, 2024 $6.36M
Long Term Debt Q2 2024 · Dec 31, 2023 $8.9M
Short Term Debt Q2 2024 · Jun 30, 2024 $3.94M
Short Term Debt Q2 2024 · Dec 31, 2023 $1.31M
Short Term Investments Q2 2024 · Jun 30, 2024 $103.09M
Short Term Investments Q2 2024 · Dec 31, 2023 $157.71M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $30.12M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $16.23M
Stockholders Equity Q2 2024 · Jun 30, 2024 $137.71M
Stockholders Equity Q2 2024 · Mar 31, 2024 $156.7M
Stockholders Equity Q2 2024 · Dec 31, 2023 $179.01M
Stockholders Equity Q2 2024 · Jun 30, 2023 $218.39M
Stockholders Equity Q2 2024 · Mar 31, 2023 $240.33M
Stockholders Equity Q2 2024 · Dec 31, 2022 $260.32M
Current Liabilities Q2 2024 · Jun 30, 2024 $16.95M
Current Liabilities Q2 2024 · Dec 31, 2023 $18.29M
Total Liabilities Q2 2024 · Jun 30, 2024 $82.3M
Total Liabilities Q2 2024 · Dec 31, 2023 $86.46M
Current Assets Q2 2024 · Jun 30, 2024 $148.7M
Current Assets Q2 2024 · Dec 31, 2023 $192.23M
Total Assets Q2 2024 · Jun 30, 2024 $220M
Total Assets Q2 2024 · Dec 31, 2023 $265.47M
Eps Diluted Q2 2024 · Jun 30, 2024 −$8.57
Eps Diluted Q2 2024 · Jun 30, 2024 −$18.72
Eps Diluted restated Q2 2024 · Jun 30, 2023 −$10.58
Eps Diluted restated Q2 2024 · Jun 30, 2023 −$20.44
Eps Basic Q2 2024 · Jun 30, 2024 −$8.57
Eps Basic Q2 2024 · Jun 30, 2024 −$18.72
Eps Basic restated Q2 2024 · Jun 30, 2023 −$10.58
Eps Basic restated Q2 2024 · Jun 30, 2023 −$20.44
Sga Expense Q2 2024 · Jun 30, 2024 $11.9M
Sga Expense Q2 2024 · Jun 30, 2024 $26.83M
Sga Expense Q2 2024 · Jun 30, 2023 $14.89M
Sga Expense Q2 2024 · Jun 30, 2023 $28.09M
Rd Expense Q2 2024 · Jun 30, 2024 $10.73M
Rd Expense Q2 2024 · Jun 30, 2024 $22.22M
Rd Expense Q2 2024 · Jun 30, 2023 $12.62M
Rd Expense Q2 2024 · Jun 30, 2023 $24.85M
Net Income Q2 2024 · Jun 30, 2024 −$21.25M
Net Income Q2 2024 · Jun 30, 2024 −$46.28M
Net Income Q2 2024 · Mar 31, 2024 −$25.02M
Net Income Q2 2024 · Jun 30, 2023 −$25.58M
Net Income Q2 2024 · Jun 30, 2023 −$49.21M
Net Income Q2 2024 · Mar 31, 2023 −$23.63M
Operating Income Q2 2024 · Jun 30, 2024 −$22.8M
Operating Income Q2 2024 · Jun 30, 2024 −$49.65M
Operating Income Q2 2024 · Jun 30, 2023 −$27.6M
Operating Income Q2 2024 · Jun 30, 2023 −$52.98M
Gross Profit Q2 2024 · Jun 30, 2024 −$178K
Gross Profit Q2 2024 · Jun 30, 2024 −$596K
Gross Profit Q2 2024 · Jun 30, 2023 −$92K
Gross Profit Q2 2024 · Jun 30, 2023 −$36K
Cost Of Revenue Q2 2024 · Jun 30, 2024 $915K
Cost Of Revenue Q2 2024 · Jun 30, 2024 $1.78M
Cost Of Revenue Q2 2024 · Jun 30, 2023 $597K
Cost Of Revenue Q2 2024 · Jun 30, 2023 $1.4M
Revenue Q2 2024 · Jun 30, 2024 $737K
Revenue Q2 2024 · Jun 30, 2024 $1.18M
Revenue Q2 2024 · Jun 30, 2023 $505K
Revenue Q2 2024 · Jun 30, 2023 $1.37M